Vienna-based Cel-Sci Corp. says it has received a $125,000 payment from Byron Biopharma as part of a deal that gives Byron marketing and distribution rights to Cel-Sci’s lead drug candidate in South Africa.
this is so true
Vienna-based Cel-Sci Corp. says it has received a $125,000 payment from Byron Biopharma as part of a deal that gives Byron marketing and distribution rights to Cel-Sci’s lead drug candidate in South Africa.
this is so true
home l faq's l buying l types l companies l advice l sitemap l resources l rss l blog